Lisdexamfetamine dimesylate
NDC 43547-605, Lisdexamfetamine dimesylate capsules, capsule, from Solco Healthcare US,LLC.
- Product NDC
- 43547-605
- Status
- Listed
- Labeler
- Solco Healthcare US,LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216266
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/43547-605 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE40 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43547-605-10 | 43547060510 | 100 CAPSULE in 1 BOTTLE (43547-605-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/68b10d9f-ca3e-493d-a309-45f1d7e08061NADAC price for package 43547060510
GET /v1/drugs/nadac/43547060510
Use it
Look up 43547-605 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43547-605 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43547-605. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.